Clinical Trial: Polypill for Prevention of Cardiomyopathy
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Type 2 Diabetes
Study Type: INTERVENTIONAL
Official Title: Polypill Strategy for Prevention of Cardiomyopathy Among Patients With Diabetes at Risk of Heart Failure
Brief Summary:
This study will investigate the utility of a polypill-based strategy for patients with type 2 diabetes mellitus and high risk of heart failure (HF), as assessed via the WATCH-DM risk score.Polypill therapy will consist of empagliflozin 12.5 mg, losartan 50 or 100 mg, and finerenone 10 mg daily.The study duration is 3 months, and participants will be randomized to either polypill therapy or usual care.The primary outcome is change in peak VO2 and adherence to usual care.The investigators hypothesize that the use of…
Read more